Sorafenib in clinical practice: evidence-based use or abuse?

Hepatology. 2012 Apr;55(4):1305; author reply 1305-6. doi: 10.1002/hep.25541.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Benzenesulfonates / administration & dosage*
  • Carcinoma, Hepatocellular / drug therapy*
  • Female
  • Humans
  • Liver Neoplasms / drug therapy*
  • Male
  • Pyridines / administration & dosage*

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Pyridines